News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
708,754 Results
Type
Article (40938)
Company Profile (256)
Press Release (667560)
Multimedia
Podcasts (52)
Webinars (12)
Section
Business (206732)
Career Advice (2021)
Deals (35825)
Drug Delivery (95)
Drug Development (81295)
Employer Resources (172)
FDA (16385)
Job Trends (14989)
News (348814)
Policy (32862)
Tag
Academia (2597)
Accelerated approval (5)
Adcomms (20)
Allergies (87)
Alliances (50355)
ALS (93)
Alzheimer's disease (1402)
Antibody-drug conjugate (ADC) (133)
Approvals (16381)
Artificial intelligence (273)
Autoimmune disease (23)
Automation (16)
Bankruptcy (364)
Best Places to Work (11703)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (176)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (292)
Cancer (2318)
Cardiovascular disease (179)
Career advice (1690)
Career pathing (30)
CAR-T (154)
Cell therapy (433)
Cervical cancer (21)
Clinical research (66224)
Collaboration (857)
Company closure (2)
Compensation (557)
Complete response letters (19)
COVID-19 (2616)
CRISPR (41)
C-suite (253)
Cystic fibrosis (102)
Data (2302)
Decentralized trials (2)
Denatured (19)
Depression (46)
Diabetes (276)
Diagnostics (6767)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (102)
Drug shortages (25)
Duchenne muscular dystrophy (97)
Earnings (87776)
Editorial (39)
Employer branding (21)
Employer resources (146)
Events (113883)
Executive appointments (743)
FDA (17759)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (770)
Gene editing (109)
Generative AI (24)
Gene therapy (309)
GLP-1 (717)
Government (4471)
Grass and pollen (4)
Guidances (150)
Healthcare (19016)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (121)
Indications (29)
Infectious disease (2762)
Inflammatory bowel disease (144)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (97)
Interviews (315)
IPO (16677)
IRA (41)
Job creations (3694)
Job search strategy (1435)
Kidney cancer (10)
Labor market (43)
Layoffs (478)
Leadership (17)
Legal (7962)
Liver cancer (78)
Lung cancer (325)
Lymphoma (156)
Machine learning (9)
Management (58)
Manufacturing (324)
MASH (73)
Medical device (13530)
Medtech (13535)
Mergers & acquisitions (19715)
Metabolic disorders (704)
Multiple sclerosis (83)
NASH (16)
Neurodegenerative disease (91)
Neuropsychiatric disorders (27)
Neuroscience (1953)
NextGen: Class of 2025 (6557)
Non-profit (4536)
Now hiring (40)
Obesity (372)
Opinion (205)
Ovarian cancer (80)
Pain (91)
Pancreatic cancer (88)
Parkinson's disease (151)
Partnered (21)
Patents (241)
Patient recruitment (116)
Peanut (47)
People (58009)
Pharmaceutical (64)
Pharmacy benefit managers (19)
Phase I (20628)
Phase II (29181)
Phase III (21712)
Pipeline (1347)
Policy (147)
Postmarket research (2567)
Preclinical (8787)
Press Release (66)
Prostate cancer (108)
Psychedelics (31)
Radiopharmaceuticals (253)
Rare diseases (383)
Real estate (6000)
Recruiting (65)
Regulatory (22563)
Reports (47)
Research institute (2361)
Resumes & cover letters (351)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (71)
Series A (132)
Series B (87)
Service/supplier (12)
Sickle cell disease (52)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (30)
Startups (3660)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (48)
The Weekly (31)
Vaccines (698)
Venture capitalists (43)
Weight loss (236)
Women's health (36)
Worklife (16)
Date
Last 7 days (929)
Last 30 days (2956)
Last 365 days (32582)
2025 (11759)
2024 (35518)
2023 (40432)
2022 (51551)
2021 (56105)
2020 (54582)
2019 (46972)
2018 (35404)
2017 (32524)
2016 (31989)
2015 (38123)
2014 (31796)
2013 (26920)
2012 (29106)
2011 (29799)
2010 (27788)
Location
Africa (734)
Alabama (54)
Alaska (7)
Arizona (235)
Arkansas (13)
Asia (38649)
Australia (6339)
California (6408)
Canada (2066)
China (534)
Colorado (272)
Connecticut (281)
Delaware (156)
Europe (83703)
Florida (947)
Georgia (218)
Idaho (57)
Illinois (552)
India (25)
Indiana (320)
Iowa (11)
Japan (172)
Kansas (107)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (923)
Massachusetts (4749)
Michigan (223)
Minnesota (409)
Mississippi (2)
Missouri (83)
Montana (27)
Nebraska (25)
Nevada (67)
New Hampshire (66)
New Jersey (1789)
New Mexico (30)
New York (1806)
North Carolina (1024)
North Dakota (8)
Northern California (2808)
Ohio (210)
Oklahoma (14)
Oregon (34)
Pennsylvania (1417)
Puerto Rico (13)
Rhode Island (33)
South America (1115)
South Carolina (25)
South Dakota (1)
Southern California (2423)
Tennessee (105)
Texas (952)
United States (24044)
Utah (191)
Virginia (151)
Washington D.C. (64)
Washington State (574)
West Virginia (3)
Wisconsin (65)
708,754 Results for "bluejay diagnostics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds
April 8, 2025
·
4 min read
Deals
Bluejay Diagnostics Announces Reverse Stock Split
Bluejay Diagnostics, Inc. today announced that the Company’s Board of Directors has approved a reverse stock split of its shares of common stock at a ratio of 1-for-8 (the “Reverse Stock Split”).
June 17, 2024
·
4 min read
Genetown
Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering
Bluejay Diagnostics, Inc. announced the closing of a firm commitment underwritten public offering with gross proceeds to the Company expected to be approximately $8.75 million, before deducting underwriting discounts and other estimated expenses payable by the Company.
June 28, 2024
·
5 min read
Deals
Bluejay Diagnostics Announces Pricing of $8.75 Million Underwritten Public Offering
Bluejay Diagnostics, Inc. today announced the pricing of a firm commitment underwritten public offering with gross proceeds to the Company expected to be approximately $8.75 million, before deducting underwriting discounts and other estimated expenses payable by the Company.
June 27, 2024
·
5 min read
Press Releases
Bluejay Diagnostics Announces Reverse Stock Split
November 14, 2024
·
4 min read
Press Releases
Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting
April 16, 2025
·
4 min read
Business
Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results
Bluejay Diagnostics, Inc. reported its financial results for the quarter and nine months ended September 30, 2023.
November 9, 2023
·
9 min read
Genetown
Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)
Bluejay Diagnostics, Inc., announced the initiation of a multicenter clinical study to evaluate the Symphony IL-6 test in sepsis patients.
December 27, 2023
·
4 min read
Press Releases
Bluejay Therapeutics Announces Upcoming Presentation of Preclinical Data in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at European Association for the Study of the Liver (EASL) Congress 2025
April 23, 2025
·
4 min read
Press Releases
Bluejay Therapeutics Reports First Preclinical Data for Liver-Targeted Fatty Acid Synthase (FASN) Inhibitor BJT-188 Being Investigated for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH)
May 7, 2025
·
5 min read
1 of 70,876
Next
